Clinical Trial News and Research

RSS

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

Results from a large clinical trial in the United States and South America indicate that AstraZeneca's COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization.

22 Mar 2021

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD).

22 Mar 2021

The hype has faded, but don’t count out convalescent plasma in Covid battle

Six months after it was controversially hailed by Trump administration officials as a "breakthrough" therapy to fight the worst effects of Covid-19, convalescent plasma appears to be on the ropes.

22 Mar 2021

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

Co-founded back in 2014 by VHIO's Laura Soucek, CEO of the enterprise, and Marie-Eve Beaulieu, Chief Scientific Officer (CSO) of the company, VHIO-born spin-off Peptomyc S.L. has just announced that it has received approval from the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain (AEMPS), to initiate the first-in-human Phase I/II clinical trial with its first compound - a disruptive Myc inhibitor, Omomyc (OMO-103).

19 Mar 2021

How effective has rapid COVID-19 vaccination been in Israel?

Despite high vaccination rates, analysis shows a definite positive impact, but patience is needed to see the real-world impacts in Israel, a pattern that may hold true in other countries also.

19 Mar 2021

SARS-CoV-2 spike stimulates hyperinflammation via Toll-like receptor 2

A new study, released on the bioRxiv* preprint server, describes the mechanism of inflammation in severe COVID-19, besides revealing a potential new therapeutic target to modulate the severity of COVID-19.

19 Mar 2021

Anti-SARS-CoV-2 drug candidate enters phase I clinical trial

DC402234 (FB2001), an anti-SARS-CoV-2 drug candidate mainly developed by research team at the Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences enters its Phase I clinical trial in the United States on March 15.

19 Mar 2021

Study: Transcendental meditation can significantly reduce severity of PTSD symptoms

Veterans with PTSD who practiced the Transcendental Meditation technique showed significant reductions in PTSD symptom severity, according to a new study published today in Journal of Traumatic Stress.

19 Mar 2021

New study provides comparative analysis of twelve COVID-19 vaccines

A new study by Novateur Ventures provides a comparative analysis of twelve COVID-19 Vaccines that had initiated or announced the Phase III clinical trial stage by early November 2020.

18 Mar 2021

Anti-inflammatory therapies may help prevent heart disease in people with age-related blood condition

Therapies that soothe inflammation could be an effective way to prevent heart disease in people with a common age-related blood condition, according to a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons.

18 Mar 2021

Immediate angiography for stroke patients linked to improved recovery, less disability

Immediate angiography, rather than the standard computed tomography (CT scan), reduced stroke treatment time and was linked to improved recovery, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2021.

18 Mar 2021

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

COVID-19 disproportionately affects men compared with women, raising the possibility that a hormone like progesterone may improve clinical outcomes for certain hospitalized men with the disease.

18 Mar 2021

Novel cancer-fighting gene therapy enters phase I clinical trial

Researchers from the MDC and Charité have developed a new gene therapy based around a special T-cell receptor that helps the immune system effectively recognize and fight cancer cells.

18 Mar 2021

New way to enhance treatment outcomes for breast cancer

Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although it can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse.

18 Mar 2021

Mobile stroke units deliver faster care to improve outcomes, lessen chance for disability

A new study involving UCLA researchers finds that mobile stroke units (MSUs) - state-of-the-art ambulances built to provide stroke patients with emergency neurological diagnosis and treatment prior to hospital arrival -- improve patient outcomes and lessen the chance for disability by delivering care faster than standard stroke care.

17 Mar 2021

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

The DREAM3R phase three clinical trial is now enrolling patients with newly diagnosed unresectable malignant pleural mesothelioma (MPM) throughout the US, Australia, and New Zealand.

17 Mar 2021

CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System

CN Bio today announced the commercial launch of its new PhysioMimix™ OOC Multi-Organ MPS.

From CN Bio 17 Mar 2021

Study could lead to the development of novel treatments for drug-resistant cancers

ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset of colorectal and gynecological cancers, could also prevent some tumors from resisting therapies by blocking a key DNA repair mechanism, researchers from Duke-NUS Medical School and the Agency for Science, Technology and Research in Singapore reported in the journal EMBO Molecular Medicine.

16 Mar 2021

URI researchers develop new, saliva-based COVID-19 test

Researchers at the University of Rhode Island have developed a new COVID-19 test that will soon be put into use across its campuses as a screening and surveillance tool for the COVID-19 virus.

16 Mar 2021

Clinical trial begins to evaluate SENSE device’s ability to monitor intracranial hemorrhage

Sense Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, announced the initiation of a multicenter pivotal trial to evaluate the safety and efficacy of a non-invasive brain scanner to monitor intracranial hemorrhage in an acute hospital setting.

16 Mar 2021

Clinical Trial News and Research

AstraZeneca's COVID-19 vaccine protects against symptomatic disease

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

The hype has faded, but don’t count out convalescent plasma in Covid battle

VHIO-born spin-off receives approval to initiate Phase I/II clinical trial of novel Myc inhibitor

How effective has rapid COVID-19 vaccination been in Israel?

SARS-CoV-2 spike stimulates hyperinflammation via Toll-like receptor 2

Anti-SARS-CoV-2 drug candidate enters phase I clinical trial

Study: Transcendental meditation can significantly reduce severity of PTSD symptoms

New study provides comparative analysis of twelve COVID-19 vaccines

Anti-inflammatory therapies may help prevent heart disease in people with age-related blood condition

Immediate angiography for stroke patients linked to improved recovery, less disability

Progesterone therapy may improve clinical outcomes for male COVID-19 patients

Novel cancer-fighting gene therapy enters phase I clinical trial

New way to enhance treatment outcomes for breast cancer

Mobile stroke units deliver faster care to improve outcomes, lessen chance for disability

Phase 3 DREAM3R trial opens for malignant pleural mesothelioma

CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System

Study could lead to the development of novel treatments for drug-resistant cancers

URI researchers develop new, saliva-based COVID-19 test

Clinical trial begins to evaluate SENSE device’s ability to monitor intracranial hemorrhage

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer